Vedanta Biosciences
Trending Articles
Related Content
Manufacturing
Vedanta Biosciences solves technical challenges with production of bacterial consortia therapies
The company has built large-scale current cGMP facility has built on the company's existing manufacturing capabilities and can produce multiple drug candidates in a manner compliant with global regulatory standards
Research & Development
BMS and Vedanta announce a new clinical collaboration to evaluate OPDIVO (nivolumab) and VE800
Bristol-Myers Squibb and Vedanta announce a clinical trial collaboration to evaluate BMS' programmed death-1 (PD-1) immune checkpoint inhibitor Opdivo (nivolumab) in combination with Vedanta’s VE800, a rationally defined human bacterial consortium, in patients with advanced or metastatic cancers